<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl6">
 <label>Table 6</label>
 <caption>
  <p>Suggested metrics by target area to improve prevention, treatment, and care for patients with liver diseases in the Asia-Pacific region</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th align="left">
     <bold>Metrics</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="2" align="left">
     <bold>Viral hepatitis</bold>
    </td>
   </tr>
   <tr>
    <td align="left">Improve coverage of hepatitis B immunisation, including a timely birth dose</td>
    <td align="left">Hepatitis B birth-dose vaccination (% coverage); three-dose hepatitis B vaccine for infants (% coverage); three-dose hepatitis B vaccine for health-care workers and other high-risk populations (% coverage)</td>
   </tr>
   <tr>
    <td align="left">Improve blood and injection safety</td>
    <td align="left">Blood donations screened with high-quality nucleic acid tests (% coverage); use safely engineered syringes and injection devices (% coverage)</td>
   </tr>
   <tr>
    <td align="left">Harm reduction for intravenous drug users</td>
    <td align="left">Number of sterile syringe or needle sets distributed per person per year for people who inject drugs</td>
   </tr>
   <tr>
    <td align="left">Improvements in sanitation and water quality</td>
    <td align="left">Households with an improved drinking water source (% coverage); households using improved sanitation facilities (% coverage)</td>
   </tr>
   <tr>
    <td align="left">Screening of high-risk groups for HBV and HCV in primary care settings</td>
    <td align="left">Proportion of patients in primary care who have been assessed for risk factors of HBV and HCV (% coverage); proportion of patients at high risk for HBV and HCV who have been tested (% coverage)</td>
   </tr>
   <tr>
    <td align="left">Increase the proportion of patients with chronic hepatitis B and C who have been diagnosed</td>
    <td align="left">Estimated proportion of patients with chronic hepatitis B and C who have not been diagnosed (% coverage)</td>
   </tr>
   <tr>
    <td align="left">Increase access to appropriate management and care for patients with chronic hepatitis B and C</td>
    <td align="left">Proportion of patients with chronic hepatitis B and C eligible for treatment with antiviral drugs (% coverage)</td>
   </tr>
   <tr>
    <td align="left">Monitor mortality related to acute and chronic hepatitis infections</td>
    <td align="left">Incidence of acute hepatitis A and E; mortality related to acute hepatitis A and E; incidence of acute hepatitis B and C; mortality related to acute hepatitis B and C; incidence of chronic HBV and HCV infections; mortality related to chronic HBV and HCV infection</td>
   </tr>
   <tr>
    <td align="left">Monitor morbidity related to chronic hepatitis infections</td>
    <td align="left">Number of patients with cirrhosis or hepatocellular carcinoma associated with HCV or HBV; number of liver transplantations for HCV or HBV; HBsAg prevalence in children younger than 5 years</td>
   </tr>
   <tr>
    <td colspan="2" align="left">
     <bold>Alcohol-related liver disease</bold>
    </td>
   </tr>
   <tr>
    <td align="left">Reduce alcohol intake and ameliorate risky alcohol-related behaviours</td>
    <td align="left">Total (recorded and unrecorded) alcohol consumed per capita (ages ≥15 years) within a calendar year in L of pure alcohol; age-standardised prevalence of heavy episodic drinking in adolescents and adults</td>
   </tr>
   <tr>
    <td align="left">Early detection and treatment of alcoholic liver diseases</td>
    <td align="left">Proportion of adult patients in primary care who have had a measure of alcohol consumption or risk in the preceding year</td>
   </tr>
   <tr>
    <td align="left">Reduce the burden of liver diseases attributed to alcohol use</td>
    <td align="left">Alcohol-related morbidity and mortality in adolescents and adults; mortality related to alcohol-attributable cirrhosis; number of patients with alcohol-related cirrhosis or hepatocellular carcinoma; number of liver transplantations for alcohol-related liver disease</td>
   </tr>
   <tr>
    <td colspan="2" align="left">
     <bold>NAFLD</bold>
    </td>
   </tr>
   <tr>
    <td align="left">Promoting physical activity</td>
    <td align="left">Prevalence of insufficient physically activity in adolescents (defined as &lt;60 min of moderate to vigorous activity daily); age-standardised prevalence of insufficiently physical activity in people aged ≥18 years (defined as &lt;150 min of moderate-intensity activity per week, or equivalent); per-capita travel (km per day)</td>
   </tr>
   <tr>
    <td align="left">Promoting healthy food consumption</td>
    <td align="left">Sugar consumption per capita (g per day); age-standardised mean proportion of total energy intake from saturated fat in people aged ≥18 years; age-standardised prevalence of people aged ≥18 years; consuming less than five total servings (400 g) of fruit and vegetables per day</td>
   </tr>
   <tr>
    <td align="left">Stopping the increase in diabetes, hyperlipidaemia, and obesity</td>
    <td align="left">Age-standardised prevalence of increased blood glucose or diabetes in children, adolescents, and adults; prevalence of overweight and obesity in children, adolescents, and adults; age-standardised prevalence of increased total cholesterol in children, adolescents, and adults</td>
   </tr>
   <tr>
    <td align="left">Early detection and treatment of NAFLD</td>
    <td align="left">Proportion of adult patients in primary care who have had their body-mass index recorded in the preceding year; prevalence of NAFLD or non-alcoholic steatohepatitis in patients in secondary care</td>
   </tr>
   <tr>
    <td align="left">Reducing the burden of liver disease attributed NAFLD</td>
    <td align="left">Number of patients with cirrhosis or hepatocellular carcinoma associated with NAFLD; number of liver transplantations for NAFLD</td>
   </tr>
   <tr>
    <td colspan="2" align="left">
     <bold>All liver diseases</bold>
    </td>
   </tr>
   <tr>
    <td align="left">Increased facilities and expertise for diagnosis, treatment, and care of patients with liver disease</td>
    <td align="left">Proportion of secondary and tertiary care hospitals with a doctor trained in liver diseases; proportion of secondary care hospitals with 24 h endoscopy facilities; survival of hospital inpatients with liver disease by cause of admission</td>
   </tr>
   <tr>
    <td align="left">Improved access to liver transplantation facilities</td>
    <td align="left">Organ donations per million people per year; waiting time for liver transplants from deceased donors by blood group; proportion of liver transplants from living donors; proportion of publicly funded tertiary care hospitals equipped for liver transplantations</td>
   </tr>
   <tr>
    <td align="left">Increasing awareness of liver disease in the general population and governments</td>
    <td align="left">Existence of Government-supported national liver plans; existence of public health-sponsored public awareness campaigns (number per year); number of patient support groups and non-governmental organisations involved</td>
   </tr>
   <tr>
    <td align="left">Research into epidemiology, risk factors, prevention, and control of liver diseases</td>
    <td align="left">Number of research papers published on liver diseases in local journals per country; proportion of research papers published on liver disease in global journals per country</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
